Trem2 is highly expressed mainly in TAMs and has been widely studied in various malignant tumors [5], including breast cancer [6], ovarian cancer [7], hepatocellular carcinoma [8], colorectal cancer [9], clear cell renal carcinoma [10] and lung adenocarcinoma [11]. Here, TREM2 is linked to cancer.